Insider trade

Officer sold ~$6.23M of CVS shares in the open market

Traded May 8, 2026 · Filed May 11, 2026

CVS HealthCVS

~$6.23M
Reported value · 70K sh @ $89.58: 10K
Holds after · shares reported: -5.9%
stock since the trade · S&P 500 +3.6%, $90.55 → $85.20 on Oct 1

Why it stands out

CVS Health's Chief Exp & Tech Officer sold $6.23M of CVS Health shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: May 8, 2026
Reporting period: Not applicable
Filed with the SEC: May 11, 2026

Officer$1M+

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$6,230,379

Shares × reported transaction price

Timing vs results

2 days after results of May 6, 2026, 89 days before results of Aug 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $90.55 on May 8, 2026, at its 52-week high, after a 27% rise over the previous 30 trading days

52-week range $58.75 (Jul 24, 2025) to $90.55 (May 8, 2026), 100% of the way up, from 251 adjusted closes. 30 trading days earlier: $71.18 on Mar 26, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on Mar 11, 2025 in the Court of Appeals for the First Circuit. A filing is an allegation, not a finding.

2 such cases were open. In Re: CVS Health Corp. Securities Act Litigation, docket 25-1230, via CourtListener (court records). Nature of suit 850, company named as first defendant